Sven Liebig

7PUBLICATIONS
60CO-AUTHORS
Gene and molecular therapyEpidemiological methodsMajor global burdens of diseaseToxicology (incl. clinical toxicology)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jan 10, 2026
High-Dose Methotrexate at All Ages: Safety, Efficacy, and Outcomes from the HDMTX European Registry.

Bertrand Pourroy, Maria D Aumente, Christian Koenecke

|Apr 12, 2025
Pneumocystis Jirovecii Pneumonia: The Potential of KEX1, MSG1, and MSG2 as Key Antigens in Cytokine Release Assays.

F A Ottilie Neumann, Markus Müller, Gregor Mattert

|Jul 12, 2024
Simplified preanalytical laboratory procedures for therapeutic drug monitoring (TDM) in patients treated with high-dose methotrexate (HD-MTX) and glucarpidase.

Franz L Knörnschild, Sven Liebig, Peggy Kießling

|Jun 08, 2024
Proteomic profiling reveals ACSS2 facilitating metabolic support in acute myeloid leukemia.

Liliana H Mochmann, Denise Treue, Michael Bockmayr

|Feb 20, 2024
Activation of gp130 signaling in T cells drives T<sub>H</sub>17-mediated multi-organ autoimmunity.

Francis Baumgartner, Stefanos A Bamopoulos, Laura Faletti

Pageof 2